论文部分内容阅读
促红细胞生成素(EPO)被认为可以提高运动员的成绩,但近日发表在《FASEB》杂志上的研究称:运动成绩提高的代价是增加脑部血管疾病的风险。研究表明:短期或长期使用促红细胞生成素(EPO)可收缩动脉,增加血压,进而减少脑部血流。该结论与之前建议促红细胞生成素(EPO)治疗中风患者的意见相反。
Erythropoietin (EPO) is considered to improve athlete performance, but a recent study published in the FASEB magazine said that the cost of improving athletic performance was to increase the risk of cerebral vascular disease. Studies have shown that short-term or long-term use of erythropoietin (EPO) can contract the arteries and increase blood pressure, thereby reducing brain blood flow. This conclusion is contrary to the previous recommendation that erythropoietin (EPO) treat stroke patients.